ASBMR e-News Weekly: June 23, 2022 Edition

Message from ASBMR President
Peter Ebeling, AO, FRACP, MBBS, MD – June 23, 2022
 

Dear Colleagues:
 
I am very happy to announce that the US Food and Drug Administration (FDA) Biomarkers Qualification Program recently accepted the ASBMR-Foundation for the National Institutes of Health (FNIH) Strategy to Advance BMD as a Regulatory Endpoint (SABRE) project team’s Qualification Plan to use the treatment-related change in bone mineral density (BMD) as a surrogate endpoint for fractures in future trials of new anti-osteoporosis drugs.
 
Indeed, this is the first qualification plan accepted by the FDA for a surrogate endpoint under the 21st Century Cures Act, a remarkable achievement for the Project Team. This team, including ASBMR members Dennis Black, Mary Bouxsein and Richard Eastell, now plans to submit a Full Qualification Package based on this approved plan for final approval by the FDA before the end of this year.
 
The ASBMR is proud to financially support this critical initiative. Achieving FDA approval to utilize BMD as a surrogate endpoint in future osteoporosis drug development trials could provide patients with more options to fight a disease that leads to debilitating fractures that cause disability, loss of independence and even death. It is also likely to attract more researchers to the musculoskeletal field, enabling a new horizon of discoveries to help our patients.
 
September’s ASBMR 2022 Annual Meeting will be the premier event for our global community to reconnect in person and discuss the latest exciting innovations and advancements in the bone, mineral and musculoskeletal field.  With more than 900 abstracts already submitted by researchers around the world and our late breaking abstract period opening soon, there will be something impactful at this year’s Annual Meeting for each of us to experience. The best way to keep abreast of the latest discoveries in bone and mineral research is to join us in Austin in September.
 
The late breaking abstract submission system is now open and will close on Wednesday, July 13. 
 
Registration is now open for the Annual Meeting. Be sure to register prior to the early-bird deadline of Thursday, July 28 to ensure you receive the lowest registration rate.
 
The Society has also secured an exclusive block of rooms at two hotels located close to the Austin Convention Center where all Annual Meeting activities will be taking place. Book your room now and secure your stay before rates increase! Lock in the discounted hotel rate by Wednesday, August 10. 
 
If you aren’t able to join us in person in Austin, Texas, USA this year, you can instead purchase our Online Experience and navigate recorded sessions from the program at your own pace following the meeting.
 
I look forward to connecting with each of you in Austin in September. And remember, your science is our progress!
 
Sincerely,
Peter Ebeling
President, ASBMR

Registration and Housing Now Open for the
ASBMR 2022 Annual Meeting!
 

Registration is now open for the Annual Meeting. Save now and register by the early-bird deadline of Thursday, July 28 to ensure you receive the lowest registration rate.
 
Save on housing for this year’s annual meeting and book through the ASBMR block of rooms at two hotels located close to the Austin Convention Center. Book your room now and secure your stay before rates increase! ASBMR Housing is available until Wednesday, August 10.

The Late-Breaking Abstract Center Is Now Open
for this Year’s Annual Meeting!
 

ASBMR invites you to submit a Late-Breaking abstract on clinical, basic and/or translational subjects that describe novel, groundbreaking research findings of the highest scientific impact. Early stage and mid-career investigators submitting Late-Breaking abstracts are eligible for an Annual Meeting travel grant. The deadline to submit your research is Wednesday, July 13.
 
Visit the Annual Meeting website for more information.

Join ASBMR for a Webinar on Single Cell Analysis in
Bone Research and Spatial Transcriptomics in Bone with
Dr. Ugur Ayturk!
 

Join us on Wednesday, June 29 at 12:00 PM EDT as Dr. Ugur Ayturk presents a webinar on “Single Cell Analysis in Bone Research and Spatial Transcriptomics in Bone.” In this webinar, Dr. Ayturk will review single cell RNA-seq technologies and their applications to skeletal biology research. He will go over the fundamentals of single cell transcriptomics technology and recent developments particularly relevant to our field. Dr. Ayturk will also provide suggestions to investigators who are interested in getting started with this technique. Please click here to register for the webinar and view additional details on the topic and speaker.

ASBMR Member Webinar - NIH Diversity Grant Supplements
Thursday, July 14, 1:00-2:00 PM EDT
 

Achieving greater diversity in biomedical research is a high priority of the National Institutes of Health (NIH), and additional funding for your lab may be available via a diversity supplement. Diversity supplements are administrative supplements sponsored by the NIH that are intended to improve the diversity of the research workforce by recruiting and supporting post-baccalaureate, predoctoral students, post-doctorates, and eligible investigators from groups that have been shown to be underrepresented in health-related research. Some supplement opportunities are also available to PI(s) of research grants who are or become disabled and need additional support to accommodate their disability in order to continue to work on the research project.
 
In this webinar hosted by the ASBMR DEI Committee, program officers from five NIH agencies will review the diversity supplement opportunities that are available, discuss the deadlines and nuanced differences between them, and answer your questions as time permits. Don’t miss this fabulous chance to learn about increased funding opportunities to further your research.
 
Participating Agencies:
•             National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
•             National Institute of Dental and Craniofacial Research (NIDCR)
•             National Cancer Institute (NCI)
•             National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
•             National Institute on Aging (NIA)
 
Click here to register for the webinar.

ASBMR Early Stage Investigator Subcommittee
Seeking Members to Serve Open Positions!
 

The ASBMR Early Stage Investigator (ESI) Subcommittee is currently accepting applications for subcommittee positions. The ESI Subcommittee seeks to advocate for and increase engagement of ASBMR members who are in the early stages of their career. This is a great opportunity for ESIs to develop and enhance their leadership skills and build connections in the field.
 
Interested in applying to serve on the ESI subcommittee? Please submit your CV and letter of interest to ASBMR Senior Membership Manager, Greg Maciog, gmaciog@asbmr.org. The deadline to submit your application is Thursday, June 30, 2022 at 11:59 PM EDT.

Follow @JBMRPlus on Twitter and
Never Miss the Latest Research and Science!
 

ASBMR members are encouraged to follow the new JBMR® Plus Twitter account (@JBMRPlus)! The society launched JBMR® Plus to increase awareness of unique journal content and engage our members and authors more creatively. In addition to promoting authors and institutions publishing in JBMR® Plus, the social media account will also feature Editor profiles, graphical abstract tutorials, open data/open science developments, news and milestones, videos, and community polls.
 
Follow @JBMRPlus for cutting-edge science presented in a wide range of high-quality articles, including technical/methods descriptions, "omics" datasets, and case reports. All articles published by JBMR® Plus are fully open access: immediately freely available to read, download and share, and ASBMR Members receive a 15% discount on article publication charges (APC) for publication in JBMR® Plus. Follow @JBMRPlus today!